MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jad.2018.11.052

Медицинская библиотека · Journal of affective disorders · 2018

Prospective associations of androgens and sex hormone-binding globulin with 12-month, lifetime and incident anxiety and depressive disorders in men and women from the general population.

Asselmann Eva, Kische Hanna, Haring Robin, Hertel Johannes, Schmidt Carsten-Oliver, Nauck Matthias, Beesdo-Baum Katja, Grabe Hans-Jörgen, Pané-Farré Christiane A

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Findings on associations of androgens and sex hormone-binding globulin (SHBG) with anxiety and depressive disorders in the general population remain inconclusive.

METHODS

We used data of n = 993 men and n = 980 women from the Study of Health in Pomerania (SHIP, a prospective-longitudinal general population study from northeastern Germany). Immunoassay-measured serum concentrations of total testosterone, androstenedione and SHBG were assessed when participants were aged 20-80. 12-month, lifetime and incident DSM-IV anxiety and depressive disorders were assessed with the DIA-X/M-CIDI at 10-year follow-up, when participants were aged 29-89. Logistic regressions were adjusted for age, smoking, alcohol consumption, physical activity, waist circumference, hypertension and oral contraceptive use (women only) at baseline and follow-up interval.

RESULTS

In men and women, androgens and SHBG were not associated significantly with incident anxiety and depressive disorders. In men, higher total testosterone predicted any 12-month (OR = 1.46) and lifetime (OR = 1.34) anxiety disorder, lifetime social phobia (OR = 2.15), and 12-month (OR = 1.48) and lifetime (OR = 1.39) specific phobia, but neither 12-month nor lifetime depression. Moreover, androstenedione in men interacted with age in predicting lifetime anxiety disorders (OR = 0.98): Higher androstenedione more strongly predicted lifetime anxiety in younger vs. older men. These findings, however, did not survive correction for multiple testing. In women, androgens and SHBG were not associated significantly with 12-month and lifetime anxiety and depressive disorders.

LIMITATIONS: The follow-up period was relatively long and other factors might have affected the examined associations.

CONCLUSIONS

Higher serum total testosterone in men and androstenedione in younger men may relate to an increased risk of anxiety disorders.

Для цитирования: Asselmann Eva, Kische Hanna, Haring Robin, Hertel Johannes, Schmidt Carsten-Oliver, Nauck Matthias, Beesdo-Baum Katja, Grabe Hans-Jörgen, Pané-Farré Christiane A. Prospective associations of androgens and sex hormone-binding globulin with 12-month, lifetime and incident anxiety and depressive disorders in men and women from the general population.. Journal of affective disorders. 2018. DOI: 10.1016/j.jad.2018.11.052.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.